To validate these clinical data in an independent cohort, we evaluated CFB mRNA expression in a publicly available pancreatic ductal adenocarcinoma dataset of The Cancer Genome Atlas (TCGA-PAAD) [20]. The gene discussed is CFB; the disease is pancreatic ductal adenocarcinoma.